{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:36:54Z","timestamp":1789879014019,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.neuropharm.2022.109079","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:36:00Z","timestamp":1652250960000},"page":"109079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7733-1831","authenticated-orcid":false,"given":"Mireia","family":"Tarr\u00e9s-Gatius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"L\u00f3pez-Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3547-6004","authenticated-orcid":false,"given":"Llu\u00eds","family":"Miquel-Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-3225","authenticated-orcid":false,"given":"Laura","family":"Castarlenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Fabius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noem\u00ed","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Vilar\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cecilia","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Casta\u00f1\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109079_bib1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behavior as a putative rat model of psychosis","volume":"290","author":"Andin\u00e9","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109079_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biopsych.2008.01.003","article-title":"The role of the cerebellum in schizophrenia","volume":"64","author":"Andreasen","year":"2008","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109079_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.schbul.a033321","article-title":"Cognitive dysmetria\u201d as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?","volume":"24","author":"Andreasen","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2022.109079_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.media.2007.06.004","article-title":"Symmetric diffeomorphic image registration with cross- correlation: evaluating automated labeling of elderly and neurodegenerative brain","volume":"12","author":"Avants","year":"2008","journal-title":"Med. Image Anal."},{"key":"10.1016\/j.neuropharm.2022.109079_bib5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.neuron.2018.06.010","article-title":"Triheteromeric GluN1\/GluN2A\/GluN2C NMDARs with unique single-channel properties are the dominant receptor population in cerebellar granule cells","volume":"99","author":"Bhattacharya","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109079_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0166-2236(90)90108-M","article-title":"Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease","volume":"13","author":"Carlsson","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0024-3205(95)02027-G","article-title":"Antagonists of the NMDA receptor-channel complex and motor coordination","volume":"57","author":"Carter","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-008-1205-9","article-title":"The absence of 5-HT1A receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex","volume":"200","author":"Casta\u00f1\u00e9","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib9","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1007\/s00213-015-3946-6","article-title":"PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments","volume":"232","author":"Casta\u00f1\u00e9","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib11","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.1073\/pnas.94.16.8854","article-title":"Nucleus reticularis neurons mediate diverse inhibitory effects in thalamus","volume":"94","author":"Cox","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2022.109079_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10571-006-9062-8","article-title":"Glutamate and schizophrenia: beyond the dopamine hypothesis","volume":"26","author":"Coyle","year":"2006","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib14","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0165-0270(89)90150-7","article-title":"The use of c-fos as a metabolic marker in neuronal pathway tracing","volume":"29","author":"Dragunow","year":"1989","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2022.109079_bib16","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2007"},{"key":"10.1016\/j.neuropharm.2022.109079_bib17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109079_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep38321","article-title":"The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory balance, neuronal oscillations and cognitive function","volume":"6","author":"Gupta","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109079_bib20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nlm.2011.01.008","article-title":"Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory","volume":"95","author":"Hillman","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2022.109079_bib21","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib22","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1017\/S1461145709990319","article-title":"Differential c-Fos induction by different NMDA receptor antagonists with antidepressant efficacy: potential clinical implications","volume":"12","author":"Inta","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2010.01.010","article-title":"Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway","volume":"471","author":"Ishii","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2022.109079_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3371\/CSRP.4.3.6","article-title":"Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models","volume":"4","author":"Kantrowitz","year":"2010","journal-title":"Clin. Schizophrenia Relat. Psychoses"},{"key":"10.1016\/j.neuropharm.2022.109079_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.mcn.2006.12.001","article-title":"Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-\u03b2-galactosidase knock-in mice","volume":"34","author":"Karavanova","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib27","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2022.109079_bib28","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1523\/JNEUROSCI.18-22-09500.1998","article-title":"The functional influence of burst and tonic firing mode on synaptic interactions in the thalamus","volume":"18","author":"Kim","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/REVNEURO.2004.15.6.383","article-title":"Tracing the neuroanatomical profiles of reward pathways with markers of neuronal activation","volume":"15","author":"Konkle","year":"2004","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2826.2008.01734.x","article-title":"Measurement of immediate-early gene activation- c-fos and beyond","volume":"20","author":"Kov\u00e1cs","year":"2008","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12311-013-0511-x","article-title":"Consensus paper: the cerebellum's role in movement and cognition","volume":"13","author":"Koziol","year":"2014","journal-title":"Cerebellum"},{"key":"10.1016\/j.neuropharm.2022.109079_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-003-1582-z","article-title":"NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development","volume":"169","author":"Krystal","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0893-133X(01)00243-3","article-title":"Effects of ketamine in normal and schizophrenic volunteers","volume":"25","author":"Lahti","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0169-328X(96)00146-5","article-title":"Cloning of the cDNA for the human NMDA receptor NR2C subunit and its expression in the central nervous system and periphery","volume":"43","author":"Lin","year":"1996","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109079_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.119.116780","article-title":"Modulation of burst firing of neurons in nucleus reticularis of the thalamus by GluN2C-containing NMDA receptors","volume":"96","author":"Liu","year":"2019","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300838","article-title":"Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice","volume":"31","author":"Long","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib37","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.neuropharm.2012.01.025","article-title":"Role of the anterior thalamic nucleus in the motor hyperactivity induced by systemic MK-801 administration in rats","volume":"62","author":"L\u00f3pez-Hill","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.05.001.2008","article-title":"In vivo 3D digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy","volume":"2","author":"Ma","year":"2008","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.neuropharm.2022.109079_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib40","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/npp.2015.316","article-title":"Multiple nicotinic acetylcholine receptor subtypes in the mouse amygdala regulate affective behaviors and response to social stress","volume":"41","author":"Mineur","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib41","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109079_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1300.065","article-title":"Glutamatergic animal models of schizophrenia","volume":"1003","author":"Moghaddam","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109079_bib45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2010.07.004","article-title":"Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism","volume":"128","author":"Neill","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2022.109079_bib46","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s007020170008","article-title":"A behavioural pattern analysis of hypoglutamatergic mice - effects of four different antipsychotic agents","volume":"108","author":"Nilsson","year":"2001","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuropharm.2022.109079_bib47","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pnpbp.2005.11.010","article-title":"Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse","volume":"30","author":"Nilsson","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109079_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-8993(99)02426-9","article-title":"The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices","volume":"857","author":"Nishizawa","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2022.109079_bib49","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","article-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs","volume":"244","author":"Olney","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2022.109079_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-2999(94)90404-9","article-title":"Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum","volume":"251","author":"Ouagazzal","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tins.2011.11.010","article-title":"GluN3 subunit-containing NMDA receptors: not just one-trick ponies","volume":"35","author":"Pachernegg","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib52","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/mp.2017.50","article-title":"Delta-frequency stimulation of cerebellar projections can compensate for schizophrenia-related medial frontal dysfunction KL","volume":"22","author":"Parker","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109079_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000113822","article-title":"The role of the cerebellum in motor control and perception","volume":"41","author":"Paulin","year":"1993","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn.2016.92","article-title":"Emerging roles of GluN3-containing NMDA receptors in the CNS","volume":"17","author":"P\u00e9rez-Ota\u00f1o","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109079_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2018.03.011","article-title":"Region-specific expression of NMDA receptor GluN2C subunit in parvalbumin-positive neurons and astrocytes: analysis of GluN2C expression using a novel reporter model","volume":"380","author":"Ravikrishnan","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109079_bib56","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.biopsych.2010.10.030","article-title":"Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine","volume":"69","author":"Santana","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109079_bib57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/1073858411435129","article-title":"Diversity in NMDA receptor composition: many regulators, many consequences","volume":"19","author":"Sanz-Clemente","year":"2013","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2022.109079_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/nbdi.1997.0136","article-title":"Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum","volume":"4","author":"Scherzer","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2022.109079_bib59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S1461145708008432","article-title":"Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine","volume":"11","author":"Scorza","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2010.04.012","article-title":"Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801. Clz and MK-801 in KO1A mice","volume":"59","author":"Scorza","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib61","doi-asserted-by":"crossref","first-page":"7572","DOI":"10.1038\/s41598-019-43957-2","article-title":"Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes","volume":"9","author":"Shelkar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2022.109079_bib62","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.neubiorev.2011.12.015","article-title":"Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia","volume":"36","author":"Shepherd","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2022.109079_bib63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9758\/cpn.2012.10.2.94","article-title":"Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration","volume":"10","author":"Shirai","year":"2012","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.neuropharm.2022.109079_bib64","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0091-3057(89)90044-0","article-title":"Acute and subchronic effects of methylenedioxymethamphetamine [(+\/-)MDMA] on locomotion and serotonin syndrome behavior in the rat","volume":"32","author":"Spanos","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109079_bib65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00213-004-1785-y","article-title":"Pharmacological and genetic evidence indicates that combined inhibition of NR2A and NR2B subunit containing NMDA receptors is required to disrupt prepulse inhibition","volume":"175","author":"Spooren","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib66","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/bph.12518","article-title":"GluN2C\/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice","volume":"171","author":"Suryavanshi","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"\u03b1-Adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2022.109079_bib68","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109079_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-2999(89)90754-1","article-title":"The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor","volume":"167","author":"Tricklebank","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib70","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.biopsych.2014.05.019","article-title":"Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain","volume":"76","author":"Troyano-Rodriguez","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109079_bib71","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.0802075105","article-title":"Rules of engagement for NMDA receptor subunits","volume":"105","author":"Ulbrich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2022.109079_bib72","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10571-004-6918-7","article-title":"Effects of NMDA-receptor antagonist treatment on c-fos expression in rat brain areas implicated in schizophrenia","volume":"24","author":"V\u00e4is\u00e4nen","year":"2004","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2022.109079_bib73","first-page":"95","article-title":"High frequency burst firing of granule cells ensures transmission at the parallel fiber to purkinje cell synapse at the cost of temporal coding","volume":"7","author":"van Beugen","year":"2013","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2022.109079_bib74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1046\/j.1471-4159.1997.68020469.x","article-title":"NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins","volume":"68","author":"Wenzel","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109079_bib75","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","article-title":"Permutation inference for the general linear model","volume":"92","author":"Winkler","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2022.109079_bib76","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00213-004-1944-1","article-title":"Bimodal effects of MK-801 on locomotion and stereotypy in C57BL\/6 mice","volume":"177","author":"Wu","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109079_bib77","first-page":"1","article-title":"Inhibition of NMDARs in the nucleus reticularis of the thalamus produces delta frequency bursting","volume":"3","author":"Zhang","year":"2009","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2022.109079_bib78","article-title":"NR2C in the thalamic reticular nucleus; effects of the NR2C knockout","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:11:40Z","timestamp":1739819500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822001381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":76,"alternative-id":["S0028390822001381"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109079","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109079"}}